Cargando…
The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders
Elevated whole-blood serotonin and decreased plasma melatonin (a circadian synchronizer hormone that derives from serotonin) have been reported independently in patients with autism spectrum disorders (ASDs). Here, we explored, in parallel, serotonin, melatonin and the intermediate N-acetylserotonin...
Autores principales: | Pagan, C, Delorme, R, Callebert, J, Goubran-Botros, H, Amsellem, F, Drouot, X, Boudebesse, C, Le Dudal, K, Ngo-Nguyen, N, Laouamri, H, Gillberg, C, Leboyer, M, Bourgeron, T, Launay, J-M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259991/ https://www.ncbi.nlm.nih.gov/pubmed/25386956 http://dx.doi.org/10.1038/tp.2014.120 |
Ejemplares similares
-
Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders
por: Pagan, Cécile, et al.
Publicado: (2017) -
Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders
por: Pagan, Cécile, et al.
Publicado: (2021) -
Heritability of the melatonin synthesis variability in autism spectrum disorders
por: Benabou, Marion, et al.
Publicado: (2017) -
Identification of Pathway-Biased and Deleterious Melatonin Receptor Mutants in Autism Spectrum Disorders and in the General Population
por: Chaste, Pauline, et al.
Publicado: (2010) -
Morning Plasma Melatonin Differences in Autism: Beyond the Impact of Pineal Gland Volume
por: Maruani, Anna, et al.
Publicado: (2019)